⚠️ “For Research Use Only. Not for Human Consumption.”
TB-500
$ 40
For In Vitro Research Use Only – Not for Human or Veterinary Application
Specifications:
· Quantity: 10mg
· Form: Lyophilized powder
· Molecular Formula: C₂₁₂H₃₅₀N₅₆O₇₈S
· Molecular Weight: ~4963.4 Da
· Purity: ≥99.9% (HPLC Verified)
Product Overview:
· TB-500 is a synthetic peptide version of a biologically active region of thymosin beta-4, studied in in vitro and preclinical research environments for its interaction with cellular migration pathways, actin-binding mechanisms, and peptide-mediated tissue signaling processes.
· In laboratory settings, researchers investigate TB-500 for its role in cellular communication systems, cytoskeletal organization pathways, angiogenic signaling activity, and biochemical processes associated with cellular movement and structural regulation.
· Due to its signaling profile and interaction with actin-regulating mechanisms, TB-500 is frequently utilized in studies involving cellular repair pathways, tissue-model signaling mechanisms, and peptide-mediated regenerative biochemical activity.
· Driven Ones LLC supplies TB-500 in a high-purity, research-grade lyophilized format, manufactured to support consistency, stability, and reproducibility across controlled laboratory research applications.
Intended Use:
· TB-500 is not approved for human or animal use.
· This product is intended strictly for in vitro laboratory research purposes only.
· Not intended for use in food, drugs, cosmetics, or diagnostic procedures.
Legal Disclaimer:
· This product has not been evaluated by the FDA.
· It is not intended to diagnose, treat, cure, or prevent any disease.
· For certified laboratories and qualified research professionals only.
Terms of Sale:
· All Driven Ones LLC sales are final.
· Purchasers affirm they are trained professionals and are responsible for proper handling, usage, and regulatory compliance.
· By purchasing, the buyer agrees to use this product strictly for lawful research purposes.

Reviews
There are no reviews yet.